Omicron Variant: BioNTech CEO Ugur Sahin Says Vaccine for New COVID-19 Variant Should Be A 3-Dose Vaccine
The vaccine for new coronavirus variant, Omicron, should be a 3-dose vaccine, said CEO of BioNTech Ugur Sahin. Notably, BioNTech has developed a vaccine against COVID-19 in collaboration with Pfizer Inc.